Last update 08 May 2026

Suzhou Gravel Biotechnology Co., Ltd.

Subsidiary Company|2020|Jiangsu Sheng, China

Overview

Tags

Neoplasms
Digestive System Disorders
TIL therapy
Interleukins

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms3
Endocrinology and Metabolic Disease2
Immune System Diseases1
Infectious Diseases1
Top 5 Drug TypeCount
TIL therapy2
Interleukins1
Top 5 TargetCount
IL-2R(Interleukin-2 receptor)1

Related

3
Drugs associated with Suzhou Gravel Biotechnology Co., Ltd.
Aldesleukin
Target
IL-2R
Mechanism
IL-2R agonists [+1]
Active Org.
Iovance Biotherapeutics, Inc.Iovance Biotherapeutics, Inc. [+11]
Originator Org.
Chiron Corp.Chiron Corp.
Active Indication
Renal Cell Carcinoma [+32]
Inactive Indication
Acquired Immunodeficiency Syndrome [+117]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
United States
First Approval Date05 May 1992
GT-101(Suzhou Gravel Biotechnology)
Target-
Mechanism
Immunologic cytotoxicity [+1]
Active Org.
Zhuhai Grit Biotechnology Co., Ltd.Zhuhai Grit Biotechnology Co., Ltd. [+3]
Originator Org.
Suzhou Gravel Biotechnology Co., Ltd.
Active Indication
Metastatic Carcinoma to the Uterine Cervix [+4]
Inactive Indication-
Drug Highest PhasePhase 2
First Approval Ctry. / Loc.-
First Approval Date-
GT-307
Target-
Mechanism-
Active Org.
Suzhou Gravel Biotechnology Co., Ltd. [+1]
Originator Org.
Suzhou Gravel Biotechnology Co., Ltd.
Active Indication
Advanced Colorectal Adenocarcinoma [+5]
Inactive Indication-
Drug Highest PhaseClinical
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Suzhou Gravel Biotechnology Co., Ltd.
CTR20233098
/ Unknown statusPhase 1
自体肿瘤浸润淋巴细胞注射液（GT201注射液）治疗晚期实体瘤的I/II期临床研究
[Translation] Phase I/II clinical trial of autologous tumor-infiltrating lymphocyte injection (GT201 injection) for the treatment of advanced solid tumors.
100 Clinical Results associated with Suzhou Gravel Biotechnology Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Suzhou Gravel Biotechnology Co., Ltd.
Login to view more data
100 Deals associated with Suzhou Gravel Biotechnology Co., Ltd.
Login to view more data
100 Translational Medicine associated with Suzhou Gravel Biotechnology Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 22 May 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
1
1
IND Application
Phase 1
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Aldesleukin
 ( IL-2R )		Solid tumor
More
Phase 1
GT-307
Digestive System Neoplasms
More
Discovery
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free